Hormone treatment may help prevent premature menopause in cancer patients

BMJ 2015; 351 doi: (Published 23 December 2015) Cite this as: BMJ 2015;351:h6916
  1. Jacqui Wise
  1. 1London

Young women with breast cancer who are given a luteinising hormone releasing hormone (LHRH) analogue, triptorelin, alongside chemotherapy are more likely to retain ovarian function, a study in JAMA shows.1

Early menopause and impaired fertility are possible consequences of cancer treatment. This can add to a patient’s distress and may also affect treatment decisions. Freezing eggs or embryos is the standard procedure for fertility preservation in patients with cancer. Administering LHRH analogues during chemotherapy to …

View Full Text

Log in

Log in through your institution


* For online subscription